Research Topic · Peer-Reviewed

Women s Health Breast Cancer

Breast cancer is a malignancy arising from the epithelial cells of the breast, most often within the ducts or lobules of the glandular tissue, and is among the most common cancers affecting women worldwide. It is a biologically heterogeneous disease shaped by the interplay of genetic, hormonal, reproductive, lifesty…

Curated from this journal's research 📚 5 peer-reviewed articles cited Cited 10× across the literature 🔖 ISSN 2381-862X 🗓 Reviewed June 2026

Overview

Breast cancer is a malignancy arising from the epithelial cells of the breast, most often within the ducts or lobules of the glandular tissue, and is among the most common cancers affecting women worldwide. It is a biologically heterogeneous disease shaped by the interplay of genetic, hormonal, reproductive, lifestyle, and environmental factors. Inherited mutations in genes such as BRCA1 and BRCA2 confer substantially elevated risk in a subset of cases, while most arise sporadically. Tumors are classified by histological type, by stage reflecting size and spread, and by molecular characteristics, particularly the expression of estrogen and progesterone receptors and the HER2 protein, which together define clinically important subtypes and guide therapy. Hormone receptor-positive tumors depend on estrogen signaling and respond to endocrine therapy, whereas HER2-positive and triple-negative subtypes require distinct approaches. Detection relies on clinical examination, mammographic and other imaging-based screening, and confirmatory biopsy, with early identification strongly improving outcomes. Treatment is typically multimodal, combining surgery, radiation, and systemic options including chemotherapy, endocrine therapy, HER2-targeted agents, and immunotherapy according to subtype and stage. Research continues into risk prediction, screening optimization, molecular profiling, and novel targeted treatments. Awareness, timely evaluation of breast changes, and access to screening and care remain central to reducing the burden of the disease among women.

Research published in this journal

5 peer-reviewed articles, ranked by relevance. Each links to its DOI.

2020

pH-Sensitive Nanomedicine for Treating Gynaecological Cancers

Vishwanath Prasad PramodCorresponding author
Center for Biomedical Research, Population Council, The Rockefeller University, 1230 York Avenue, New York, NY 10065, USA
Women's Reproductive Health Cited by 8 doi:10.14302/issn.2381-862X.jwrh-19-3143

How this research is being cited

The 5 articles above have been cited 10 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Women s Health Breast Cancer, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Women's Reproductive Health (ISSN 2381-862X).

Journal editorial board
Paolo Ivo Cavoretto · Italy Loc Nguyen · Hong Kong Matteo Schimberni · Italy

This page summarises published research for orientation; it is not medical or professional advice.